Wheeler Bio has announced the closing of an oversubscribed $35 million Series A-1 financing round, led by Alloy Therapeutics and Echo Investment Capital. This funding will enable Wheeler to expand its partner base and manufacturing capabilities.
Amount Raised
$35 Million
Round Type
Series A
Oklahoma CityBiotechnologyHealth CareScience And EngineeringInvestors
Description
Wheeler Bio, a contract development and manufacturing organization, has closed a $35 million Series A-1 financing round. The round was led by Alloy Therapeutics and Echo Investment Capital, with participation from Mitsubishi Corporation (Americas), Germin8 Ventures, and Russell Westbrook Enterprises. This investment will help Wheeler enhance its capabilities and facilitate the expansion of a new large-scale biologics manufacturing facility. The funding is crucial for advancing the development of antibody-based therapies.
Quick answer
Wheeler Bio raised $35 Million in a Series A round, dated March 20, 2025. Investors: Mitsubishi Corporation (Americas), Germin8 Ventures, Russell Westbrook Enterprises, Alloy Therapeutics and Echo Investment Capital. Wheeler Bio is based in Oklahoma City, Oklahoma, United States.
- How much did Wheeler Bio raise?
- Wheeler Bio raised $35 Million in a Series A round on March 20, 2025.
- Who invested in Wheeler Bio?
- Mitsubishi Corporation (Americas), Germin8 Ventures, Russell Westbrook Enterprises, Alloy Therapeutics and Echo Investment Capital are named as investors in this round.
- What does Wheeler Bio do?
- Wheeler Bio is a contract development and manufacturing pioneer who has established the ModularCMC™ platform that enables the rapid translation of antibody-based therapeutics from discovery to clinical studies while..
- Where is Wheeler Bio based and how big is it?
- Wheeler Bio is based in Oklahoma City, Oklahoma, United States. Fundz records about 75 employees.
- Who are the decision-makers at Wheeler Bio?
- Fundz holds 1 contact at Wheeler Bio. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Science And Engineering and Biotechnology around the same time
Companies in the same sectors as Wheeler Bio that raised within 45 days of this round, from Fundz verified event records.
- Garuda Therapeutics raised $50M (Series A) on March 5, 2025.
- MAIA Biotechnology raised $4.1M (Seed) on February 18, 2025.
- Septerna raised $288M (IPO) on February 14, 2025.
- Azora Therapeutics, Inc. (DE) raised $4.8M on May 2, 2025.
- EnChannel Medical raised $82M (Series B) on May 1, 2025.
- DarioHealth raised $33M (Debt Financing) on May 1, 2025.
Who to call at Wheeler Bio, and when
A new round usually means Wheeler Bio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Wheeler Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Wheeler Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Wheeler Bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Wheeler Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansWheeler Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.